Device
Diagnostic MRI
Diagnostic MRI is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
NCT04218617
completednot_applicable
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
NCT03585660
completed
Evaluation of Upper Abdomen Imaging With Low Field MRI Scanner (0.4T)
NCT06049563
Clinical Trials (3)
Showing 3 of 3 trials
NCT04218617Phase 2
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
NCT03585660Not Applicable
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
NCT06049563
Evaluation of Upper Abdomen Imaging With Low Field MRI Scanner (0.4T)
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3